Back to Press Releases
Kyocera Medical Technologies, Inc.·Press Release
Kyocera Medical Technologies, Inc. Announces Launch of Tesera®-K XL System, Advancing 3D-printed Lateral Spine Surgery Solutions
Monday, August 3, 2026
Kyocera Medical Technologies, Inc. Announces Launch of Tesera®-K XL System, Advancing 3D-printed Lateral Spine Surgery Solutions
REDLANDS, CA — July 7, 2026 — Kyocera Medical Technologies, Inc. is proud to announce the launch of the Tesera®-K XL Lateral Interbody Fusion System, enabling minimally invasive spinal surgery to treat lower back and leg pain from a lateral approach.
This product is the latest innovation in Kyocera’s expanding portfolio of interbody fusion solutions. Designed to address the evolving needs of spine surgeons, Tesera®-K XL combines cutting-edge material science and manufacturing processes with versatile instrumentation to support improved surgical access and patient outcomes.
The Tesera®-K XL System features Kyocera’s latest Resilience® low-modulus technology, an advanced 3D-printed titanium design engineered with a dual-wall lattice structure. With approximately 68% porosity, the cage is specifically optimized to promote load sharing and enhance fusion. The addition of DUO-Texture® micro and macro texturing further supports bone on-growth and in-growth, reinforcing the system’s long-term performance and durability.
Designed with surgical flexibility in mind, Tesera®-K XL incorporates straight and angled instrumentation to facilitate access to the lateral spine, particularly in patients with high iliac crest anatomy or when utilizing an anterior-to-psoas approach. The innovative Omni-Angle inserter enables surgeons to use a single instrument across multiple approaches and patient positions, streamlining procedural efficiency.
With a comprehensive range of footprints and lordotic options, Tesera®-K XL empowers surgeons with the versatility needed to address complex anatomies and surgical preferences.
________________________________________
About Kyocera Medical Technologies, Inc.
Kyocera Medical Technologies, Inc. is committed to providing high-quality orthopedic and spine solutions that enable surgeons to address the unique needs of every patient. Built on Kyocera’s global reputation for innovation, precision, and quality, the company combines advanced biomaterials with thoughtful product design to deliver exceptional performance, reliability, and clinical outcomes.
The company’s portfolio includes comprehensive solutions for both spine surgery and adult reconstruction. Its spine product offering features systems for anterior cervical and anterior lumbar fusion in both traditional and standalone configurations, as well as posterior, transforaminal, and lateral approaches. These systems are available in a wide range of footprints and lordotic angles, providing surgeons with the flexibility to accommodate diverse patient anatomies and surgical techniques. Kyoto, Japan-based Kyocera Corporation, the parent and headquarters of the global Kyocera Group, is a manufacturer specializing in advanced materials, with more than 70,000 employees and consolidated annual revenue of $13.7 billion in the fiscal year ending March 31, 2026.
For additional information regarding Kyocera Medical Technologies, Inc. products, clinical support, distribution opportunities, or strategic partnerships, please contact us at (909) 557-2360, KMTI.Orders@kyocera-medical.com, or visit www.kyocera-medical.com. Our team is committed to providing responsive support and helping healthcare professionals deliver exceptional patient care.
REDLANDS, CA — July 7, 2026 — Kyocera Medical Technologies, Inc. is proud to announce the launch of the Tesera®-K XL Lateral Interbody Fusion System, enabling minimally invasive spinal surgery to treat lower back and leg pain from a lateral approach.
This product is the latest innovation in Kyocera’s expanding portfolio of interbody fusion solutions. Designed to address the evolving needs of spine surgeons, Tesera®-K XL combines cutting-edge material science and manufacturing processes with versatile instrumentation to support improved surgical access and patient outcomes.
The Tesera®-K XL System features Kyocera’s latest Resilience® low-modulus technology, an advanced 3D-printed titanium design engineered with a dual-wall lattice structure. With approximately 68% porosity, the cage is specifically optimized to promote load sharing and enhance fusion. The addition of DUO-Texture® micro and macro texturing further supports bone on-growth and in-growth, reinforcing the system’s long-term performance and durability.
Designed with surgical flexibility in mind, Tesera®-K XL incorporates straight and angled instrumentation to facilitate access to the lateral spine, particularly in patients with high iliac crest anatomy or when utilizing an anterior-to-psoas approach. The innovative Omni-Angle inserter enables surgeons to use a single instrument across multiple approaches and patient positions, streamlining procedural efficiency.
With a comprehensive range of footprints and lordotic options, Tesera®-K XL empowers surgeons with the versatility needed to address complex anatomies and surgical preferences.
________________________________________
About Kyocera Medical Technologies, Inc.
Kyocera Medical Technologies, Inc. is committed to providing high-quality orthopedic and spine solutions that enable surgeons to address the unique needs of every patient. Built on Kyocera’s global reputation for innovation, precision, and quality, the company combines advanced biomaterials with thoughtful product design to deliver exceptional performance, reliability, and clinical outcomes.
The company’s portfolio includes comprehensive solutions for both spine surgery and adult reconstruction. Its spine product offering features systems for anterior cervical and anterior lumbar fusion in both traditional and standalone configurations, as well as posterior, transforaminal, and lateral approaches. These systems are available in a wide range of footprints and lordotic angles, providing surgeons with the flexibility to accommodate diverse patient anatomies and surgical techniques. Kyoto, Japan-based Kyocera Corporation, the parent and headquarters of the global Kyocera Group, is a manufacturer specializing in advanced materials, with more than 70,000 employees and consolidated annual revenue of $13.7 billion in the fiscal year ending March 31, 2026.
For additional information regarding Kyocera Medical Technologies, Inc. products, clinical support, distribution opportunities, or strategic partnerships, please contact us at (909) 557-2360, KMTI.Orders@kyocera-medical.com, or visit www.kyocera-medical.com. Our team is committed to providing responsive support and helping healthcare professionals deliver exceptional patient care.